510(K) CLEARANCES 51 ▲2RECALLS POSTED 25 ▲2CLASS I 1PMA DECISIONS 50 ▲13WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K102535Substantially Equivalent

Etest Telavancin in 0.002-32 Ug/ml and 0.016-256 Ug/ml

bioMerieux, Inc., Craponne, FR / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)

K102535 is the FDA 510(k) clearance record for ETEST TELAVANCIN IN 0.002-32 UG/ML AND 0.016-256 UG/ML, a class II device, cleared for Biomerieux S.A. on under FDA product code JWY (Manual Antimicrobial Susceptibility Test Systems). FDA records list 408 510(k) clearances for Biomerieux S.A., from to . As of , FDA records show no recalls naming K102535.

Clearance record

Decision date
Received
(255 days to decision)
Product code
JWY Manual Antimicrobial Susceptibility Test Systems
Regulation
21 CFR 866.1640
Device class
Class II
Review panel
Microbiology
Applicant
Biomerieux S.A. 5 Rue Des Aqueducs, Craponne, FR
510(k) summary
Statement
Third party review
No

Clearances, product code JWY

Trailing 12 months
2 clearances under product code JWY in the twelve months to November 2026, April 2026 the highest month at 2.
Show the numbers
Monthly 510(k) clearances under FDA product code JWY, trailing twelve months
MonthClearances
December 20250
January 20260
February 20260
March 20260
April 20262
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260
November 20260